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Efficacy And Safety of PLATELET RICH PLASMA (PRP) for 
treatment of acne scars 
ABSTRACT 
Key words: Acne scars, Platelet rich Plasma 
INTRODUCTION: 
            Acne scarring can produce severe disfigurement of face. Scarring is a 
complex biological process that involves various chemical mediators, 
extracellular matrix, parenchymal resident cells and infiltrating blood cells. 
            Autologous PRP has been found to stimulate fibroblast growth and 
therefore helps in scar healing. Modern technology allows us to concentrate 
platelets and white blood cells from a patient’s blood (autologous therapy) 
and to induce the release of growth factors by injecting the solution directly 
into injured tissue, stimulating the same healing process but in a more 
directed form. 
METHODS AND MATERIALS: 
         Forty patients of atrophic acne scars attending  Dermatology OPD 
in Govt. Stanley Hospital during period from JUNE 2013 to MAY 2014 
were selected. After brief & relevant medical history and physical 
examination, acne scars were graded. Informed consent and digital 
photographs of face were taken. PRP was injected by multiple tiny 
punctures under the dermis under topical anesthesia. Up to 6 sittings, 4 
weeks apart were given within a 6-month time frame. At the end of 
treatment duration, scars were graded using grading system as used in the 
beginning, photographs taken and compared. 
OBSERVATIONS: 
          Marked improvement was seen in 42.5 % patients while 35% patients 
showed moderate improvement. In maximum patients improvement became 
visible at the end of 3
rd
 sitting. Patient satisfaction was good in 52.5% 
patients and very good in 27.5 % cases. There was a good reduction in DLQI 
too (61.13 % improvement ).Complications seen were only in form of 
transient erythema and pain. 
 CONCLUSION: 
Marked to Moderate improvement was seen in most cases, which is 
comparable with other modalities used for management of acne scars. It  
does not hamper daily activity of the patient as it is performed as out-patient 
procedure. To conclude Platelet rich plasma therapy is easy to perform and 
provides satisfactory results and that too with minimum side effects. 
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Acne is a disease of pilosebaceous unit, most commonly affecting 
adolescents, clinically characterized by pleomorphic variants of lesions 
like papules, pustules, comedones, nodules and cysts . It is in most cases 
a self-limiting disease. It is however associated with variable amount of 
scarring, so there can be life long sequelae in form of atrophic or 
hypertrophic scar formation. In some patients, the scarring is minimal, 
however in some scarring may be severe.The cause of this scarring is 
basically defective wound healing. 
Scars resulting from acne may be of following types: 
1) Ice pick scars 
2) Rolling scars 
3) Box car scars 
4) Hypertrophic scars 
5) Perifollicular elastolysis 
6) Perifollicular fibrosis 
7) Atrophic macules. 
Different types of scars may be present in a same patient. 
Management of acne scars usually involves combination of different 
modalities. 
2 
 
Various methods in use for acne scar management are: 
1) Use of topical agents like tretinoin, steroids. 
2)  Punch elevation, Punch graft. 
3)  Subcision 
4) Microdermabrasion 
5) Dermabrasion 
6) Lasers 
7) Fillers 
Apart from these conventional procedures, use of Platelet Rich 
Plasma (PRP) for acne scars is gaining popularity. PRP, in which the 
platelets are in highly concentrated form has shown its effect in 
accelerating tissue repair & wound healing. It therefore holds a role in 
treatment of acne Scars. It can be used either alone or in combination 
with other methods. The scarring in acne occurs due to defective tissue 
healing after the inflammation occurring during the disease process. The 
platelets release a variety of growth factors including Transforming 
Growth Factor, Fibroblast Growth Factor and Vascular Endothelial 
Growth Factor. 
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These factors have the potential to bring about tissue re-modelling 
by regulating cell migration, proliferation, differentiation and extra 
cellular matrix accumulation. Autologous PRP is a latest advancement, a 
more natural procedure, in which the platelets extracted from one’s own 
blood are re-injected into the body, into the area where the effect is 
desired so that the platelets carry out the function in a more directed way. 
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ACNE  
HISTORY 
ACNE is not a disease of modern age alone. The First description 
of acne can be found in the Sushrut Samhita under Kshudra Roga as 
Mukha Dushika. Mentions are found in ancient Egyptian writings about 
this condition in the Pharaoh and various treatments used by them. Some 
sources say that it was Emperor Justinian’s physician, Aetius Amidenus, 
who used the word ‘ACNE’or the first time during sixth century A.D. 
Word ACNE comes from word ‘AKME’. It is actually corrupt form of 
the word AKME, which means ‘PRIME OF LIFE’[1]. 
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EPIDEMIOLOGY 
Acne vulgaris, also called as ‘pimples’, by common people is a 
universal disease affecting about 9.4% population globally
[2]
. Around 
90% people get affected in their teens & in some it persists till adulthood. 
In India prevalence rate is about 50.60% in males and 38.13% in females, 
in age group of 12-17 years
[3]
. However its  sequel that is scarring 
continues in adulthood. 
Difference in male and female prevalence is often reported, but it is 
more due to social biasing. Studies have also shown difference in the 
prevalence of acne in rural and urban areas
[4]
. 
It is believed to be more common in urban population, suggesting 
the role of lifestyle and diet in the occurrence of acne.Around 20 % have 
severe acne which can result in permanent physical as well as mental 
scarring. 
DEFINITION 
Acne is a self-limiting inflammatory disease of pilosebaceous units 
seen predominantly in adolescents, characterised by seborrhoea & 
pleomorphic lesions like open and closed comedones, erythematous 
papules, pustules, nodules, cysts and in many cases scarring will ensue 
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which can be either mild or severe, depending upon the degree of 
inflammation
[5]
. 
The condition is most common between 12-25 years. Acne is 
undoubtedly one of the most common conditions encountered by the 
Dermatologists. 
ETIOPATHOGENESIS 
SEBACEOUS GLANDS AND SEBUM: 
Sebaceous gland is a holocrine gland. They occur over most of the 
body, but not normally over palms and soles and sparsely over the 
dorsum of hands and feet. Sebaceous glands are largest and most 
numerous on face, scalp, upper trunk, external auditory meatus and 
anogenital surfaces.  
There are between 400-900 glands/ cm
2 
over scalp, forehead, face 
and chin
[6]
. At other places they are less than 100glands /cm
2
. Sebaceous 
glands are active in newborn, but later they involute and become  
non-functional until puberty. Sebum is a complex mixture of lipids, 
consisting of glycerides, free fatty acids, wax esters, squalene, cholesterol 
esters and cholesterol. Sebum is fungistatic.  
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PRECIPITATING OR AGGRAVATING FACTORS 
1) Hormonal 
Periods of excessive hormonal activity, such as menstrual cycles 
and puberty, may contribute to the formation of acne. An increase in 
androgens during puberty causes enlargement of follicular glands and 
increased sebum production. Similar effect is shown by use of anabolic 
steroids. It has also been seen that acne develop earlier in females than 
males, which may be due to earlier onset of puberty in girls. Hormones 
linked to acne are: the androgens
[7] 
testosterone, dihydrotestosterone 
(DHT) and dehydroepiandrosterone sulfate (DHEAS), as well as insulin-
like growth factor 1 (IGF-I). 
Late onset acne is not common. Acne vulgaris in an adult women 
can be due to any underlying condition such as pregnancy, polycystic 
ovary syndrome, hirsutism, or Cushing's syndrome. 
Acne climacterica : 
It is Menopause associated acne which occurs as the production of 
the natural anti-acne ovarian hormones estradiol and progesterone fails, 
permitting  the unopposed action of the  acnegenic hormone testosterone. 
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2) Genetics 
Positive family history has been seen in patients with severe 
persistent acne.
[8]
 In monozygotic twins sebum excretion rate is same.The 
genetics of acne susceptibility is most likely polygenic, as the disease 
does not follow classic Mendelian inheritance pattern. 
3) Cosmetics 
Heavy use of cosmetics can cause flare up of acne. It may be due 
to blocking of the pilosebaceous orifices by the chemicals. External 
application of oil, pomades (pomade acne)  etc.  can cause acne. 
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4) Sweating 
Acne patients usually notice aggravation of acne by sweating. Hot   
and humid climate aggravates acne, due to increased sweating which 
causes ductal hydration
[9]
.
 
5) Menstrual flare 
Premenstrual flare is probably due to altered hydration of 
pilosebaceous epithelium
[10]
. 
6) Sunlight 
There is no scientific evidence that sunlight improves acne, the 
improvement seen may be due to the cosmetic effect of tanning . 
7) Stress 
There exists a ‘stress-acne-stress’ cycle. Stress causes deterioration 
of acne. Acne itself causes stress. Under stress, body secretes stress 
hormone Cortisone, which causes increased production of testosterones, 
resulting in sebaceous gland stimulation and paving way for acne 
formation. Patients meddling with the lesions further causes aggravation 
of lesions. 
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8) Smoking 
Causes exacerbation of acne. Smoke contains polycyclic aromatic 
hydrocarbons and arachidonic acid, which induce phospholipase A 
dependent inflammatory pathway
[11]
. Smokers also consume diet 
containing high saturated fat   and lower polyunsaturated, linoleic acid 
compared to those who do not smoke. 
9) Diet  
Foods with high glycemic index, milk products, sweets, chocolates 
are known to exacerbate acne. They cause hyperinsulinemia leading to 
increased androgen synthesis
[12]
 . 
10) Drugs 
Steroids, anticonvulsants, isoniazid, pyrazinamide, lithium, 
risperidone, vitamin B12 are known to induce acne like eruptions. 
11) Racial Differences 
Although acne affects all population, few racial differences are 
known. Japanese are said to be less affected than Americans. Also cystic 
acne is more common among the Whites. 
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PATHOGENESIS OF ACNE 
Pathogenesis of acne vulgaris is multifactorial. Main factors involved are: 
1)  Seborrhoea 
2)  Ductal hyperproliferation 
3) Propionibacterium acnes  colonization 
4)  Inflammation 
SEBORRHOEA 
Excess sebum production is a pre-requisite for acne formation
[13]
. 
The level of sebum production correlates well with the severity of acne. 
This Sebaceous activity is under the control of androgens, which can be 
of gonadal or adrenal origin. In androgen insensitive subjects, there are 
no androgen receptors, there is no sebum production and no acne 
develop. The Dehydroepiandrosterone sulphate is converted to 
Dihydrotestosterone (DHT)and this binds to sebocyte resulting in excess 
sebum production anddevelopment of comedones in acne prone persons. 
Androgens regulate function by binding to nuclear androgen receptors 
(ARs) present in the sebaceous gland. 
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Dehydroepiandrosterone  sulphate ( DHEAS) 
 
Dihydrotestosterone (DHT) 
 
Nuclear Androgen Receptors( AR ) over sebocytes 
 
Increased sebum production 
 
 
Changes in the ductal microenvironment 
 
     Acne 
Androgen effects on the pilosebaceous unit are reasonably well 
documented. Testosterone and DHT act through a single nuclear 
androgen receptor, with dihydrotestosterone (DHT) as the most active 
ligand. Sebum excretion varies from follicle to follicle. In acne patients, 
there is marked variation in individual follicular sebum excretion. This 
hypothesizes that certain follicles may be prone to acne and that an 
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enhanced peripheral (end organ) response to androgens is a probable 
factor. Weak prohormones (DHEA, DHEAS and androstenedione) only 
act after conversion to more potent androgens testosterone and  
5α-DHT. Sebaceous glands in some areas show abnormally high  
5α-reductase activity. In addition, abnormally high levels of plasma DHT 
and urinary 5α-androstanediols, considered to be biological markers of 
cutaneous androgen metabolism. This has been identified in some female 
acne patients. Androgen action on the sebaceous gland may be 
independent of serum hormone levels.  
There are two forms of 5α-reductase. 5α-reductase type-I is the 
most relevant in acne supported by the fact that Finasteride, an inhibitor 
of type II 5α-reductase, does not reduce sebum production and the fact 
that patients with a deficiency of type II 5α-reductase have normal sebum 
levels. Regional differences in the activity of type I 5α-reductase in 
isolated sebaceous glands from various body sites also support the  
end-organ hyper-responsiveness theory for acne. 
Mechanism for increased sebum production under androgen effect  
 Excess androgen production 
 Increased free circulating androgens which may be accompanied 
by relative reduction of sex hormone binding globulin (SHBG). 
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 Increased response of target cells 
 Increased capacity of receptors to bind androgens. 
Sampling from skin surface lipids has shown that patients with 
acne tend to have higher level of squalene and wax esters, while fatty 
acids are at lower levels. Linoleic acid is significantly reduced in 
epidermal and comedonal lipids, relating with ductal hyperproliferation. 
DUCTAL HYPERPROLIFERATION 
The infundibular portion becomes hyperkeratotic .The stimulus to 
this hyperkeratosis may be androgens or due to the irritating effect of 
sebaceous lipids. Also there is increased cohesion of keratinocytes.This 
leads to formation of a plug in follicular ostia in which bacteria, sebum, 
keratin gets accumulated. As a result there is dilatation of follicle leading 
to microcomedone formation. Several factors have been implicated in 
inducing keratinocyte hyperproliferation. These include sebaceous lipid 
composition, androgens, cytokines produced locally andbacteria.Among 
abnormal sebaceous lipids, linoleic acid levels are of importance. Among 
the cytokines produced by keratinocytes, levels of IL-1- alpha are 
important pathologically
[14]
. 
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Certain externally applied chemicals present in cosmetics like 
isopropyl myristate and propylene glycol may also contribute to 
comedogenesis. 
PROPIONIBACTERIUM ACNES COLONIZATION 
Acne is not an infectious disease. But in case of inflammatory 
acne, the blocked pilosebaceousduct may get infected with P. acnes when 
it gets trapped in the cornified plugs within the ducts. Propionibacterium 
acnes causes production of proinflammatory cytokines (like IL-8 & 
Human –beta-defensin-2) by binding through Toll like receptors[15] .They 
are responsible for breakdown of  triglycerides to free fatty acids which 
leads to follicular hyperkeratosis. It also produces other chemotactic and 
proinflammatory substances. Powerful hydrolytic enzymes levels rise, 
making tissue damage inevitable. 
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TOLL LIKE RECEPTORS:   
These are a class of proteins which play important role in body’s 
innate immunity. They are actually a type of pattern recognition receptor. 
Thirteen TLRs have been identified in humans. P. acnes activates TLR-2 
on keratinocytes and monocytes thus causing production of pro-
inflammatory cytokines. 
 
INFLAMMATION 
It is the major cause of scarring. Linoleic acid, which is known to 
be deficient in acne, could lead to an alteration in the integrity of the 
barrier function within individual follicles
[16]
. Basement membrane of the 
follicle wall remains intact in uninvolved follicles. An unknown soluble 
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antigen could be a trigger for inflammation. Inflammation up regulates 
sebum production, in genetically predisposed individuals, which 
elaborates IL-1 alpha initiating comedogenesis. 
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RECENT CONCEPTS: 
It has been believed for long that the initial lesion of acne is non –
inflammatory. After colonization with P. acnes, due to the innate immune 
response, the inflammation starts leading to formation of so called 
inflammatory lesions i.e. papule, pustule or nodule. However recent 
evidences and studies support that inflammation is present during all the 
stages of acne, may be sub-clinically, even before comedone 
formation
[17]
. The uninvolved skin in acne patients has been found to 
contain elevated levels of CD3+ and CD4+ T cells in the perifollicular 
and papillary dermis. Lipoperoxidation brings about modification of 
sebum composition which can affect keratinocytes proliferation and 
differentiation. Lipid peroxidation products can induce production of pro-
inflammatory cytokines and activation of peroxisome proliferators-
activated receptors (PPARs). PPARs are transcription factors involved in 
control of inflammation. 
CLINICAL FEATURES 
CONSISTS OF INFLAMMATORY & NON INFLAMMATORY 
LESIONS. COMEDONES are the non- inflammatory lesions - They are 
the characteristic early lesions. 
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Types of comedones: 
Open comedones-   Also known as Black Heads. Dome shaped papules 
with dilated follicular outlets filled  with keratin. The visible black colour 
is due to melanin deposit. 
Closed comedones- Also known as White Heads. Around one mm in 
diameter, skin coloured and there is no visible follicular opening. They 
can be visualised properly in adequate light and by stretching the skin. 
Submarine comedones-  They are larger. Greater than 0.5 cm in 
diameter. They lie more deeply in skin. They may be the source of 
recurrent inflammatory nodular lesion. 
Sandpaper comedones- Multiple, very small white heads, commonly 
over forehead. There is a rough, gritty feeling on touching. 
Secondary comedones – They are caused by exposure to dioxins, 
pomades, topical steroids. 
Inflammatory lesions include superficial lesions like papules and 
pustules (5 mm or less in diameter) & deep lesions like pustules and deep 
nodules. Nodules are seen more frequently in males. They may be 
hemorrhagic or exudative, leading to disfigurement. 
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When sinuses are formed between pustules and nodules, it leads to 
devastating cosmetic disfigurement and inevitable scarring
[18]
. Scarring 
usually follows deep-seated inflammatory lesions, but may also occur as 
a result of more superficial inflamed lesions in scar-prone patients. 
Patients may rarely complain of itching, which may be due to 
release of histamine like substance from P. acnes. 
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GRADING OF ACNE 
There are various methods for grading severity of acne: Simple 
grading  by Indian authors:
[19]
 
Grade 1 : Mainly comedones, occasional papules 
Grade 2 : Comedones, many papules, few pustules. 
Grade 3: Predominantly pustules, nodules, abscesses 
Grade 4: Mainly cysts or abscesses, widespread scarring 
IAA (Indian Acne Alliance)grading of acne 
Mild Acne ( Grade 1) 
Predominance of comedones 
Comedones<30 
Papules  < 10 
No scarring 
Moderate Acne ( Grade 2) 
Predominance of papules 
Comedones any number  
Papules> 10 
Nodules< 3 
Scarring +/- 
Severe Acne ( Grade 3) 
Many Nodules 
Comedones any number 
Papules any number 
Nodules/Cyst >3 
Scarring + 
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GLOBAL ACNE GRADING SYSTEM
[20] 
LOCATION FACTOR 
Forehead 2 
Right cheek 2 
Left cheek 2 
Nose 1 
Chin 1 
Chest & upper back 3 
 
No lesions- 0 
Comedones-1 
Papule -2 
Pustule- 3 
Nodules-4 
Local score = Factor X grade (0-4 ) 
GLOBAL SCORE is sum of local scores. 
1 - 18 – mild     31-38 - severe 
19 - 30 – moderate     >39 - very severe 
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MECHANISM OF ACNE SCAR FORMATION 
Scarring in acne occurs due to abnormal healing process that 
occurs after the damage caused due to inflammatory process during the 
course of disease. These inflammatory events are brought about by cell 
mediated immune response. Scarring in acne is determined by severity of 
inflammation as measured by depth and duration. 
However, strangely scarring doesn’t occur in all patients of acne. 
Studies have found difference in infiltrate in the lesions of patients who 
develop scarring & those who do not
[21]
 . In lesions from acne patients 
who were vulnerable to scar, a predominantly adaptive immune response 
was present, which was persistent and up-regulated in resolving lesions. 
The number of CD4 T cells was approximately half of those found in 
lesions of non-scarrers, but a high percentage of these cells were skin 
homing memory/effector cells, suggesting that these patients were 
sensitized to the causative antigens.
 
In developing lesions, although the numbers of macrophages, 
blood vessels and vascular adhesion molecules were high and similar to 
those present in lesions of non-scarrers, the numbers of langerhans’ cells 
and the level of cellular activation were low, and comparable to levels 
found in normal skin, indicative of an ineffective response. However, in 
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resolving lesions, there was an up-regulation of the response with greater 
cellular activation and a further influx of macrophages and skin homing 
memory/effector cells. Certainly, the strong macrophage presence 
represents a dominant force in this response. 
Keloidal scar occur on dark skin and is mapped to chromosome 
2q23 and p11
[22]
. Damage to epidermis resulting in erythema and 
pigmentation is reversible, while damage to dermis resulting in atrophic 
scars is partially reversible and is irreversible in hypertrophic scars. 
Remodelling of collagen, the final step in tissue repair, is mediated by 
Matrix Metalloproteinases (MMP 1,2,9  and others) that cause the 
damage, and Tissue Inhibitors of Metalloproteinases (TIMP 1, 2, 3 
mainly)  which reduce the damage
[21-28]
. Alteration of ratio of 
MMPs/TIMPs, when is minimal atrophic scar occurs, when the ratio is 
more hypertrophic scar occurs. 
In acne patients not prone to scarring, the time course was typical 
of a type IV delayed hypersensitivity response. In developing lesions 
there was significant angiogenesis and vascular adhesion molecule 
expression, with a large influx of activated CD4 T cells, macrophages 
(CD68) and Langerhans’ cells (CD1a)[29]. Cell recruitment peaked at  
48 hours after which there was a decrease in leukocytes, cellular 
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activation and a return to normal levels of blood vessels and vascular 
adhesion molecules in resolving lesions. Of the CD4 T cells, 50% were 
skin homing memory effector cells (CD45RO, CLA) and naïve cells 
(CD45RA) cells, whilst the remainder were unclassified 
(CD45RO−,CD45RA−, CLA−) which suggests that effective resolution 
occurred by both non-specific / innate and adaptive immune 
mechanisms
[30]
 . 
INFLAMMATION 
 
VASODILATATION & ERYTHEMA & MELANOGENESIS 
(Post acne erythema and Hyperpigmentation) 
 
 
Macrophages, Neutrophils Lymphocytes, Fibroblasts, and Platelets activated 
 
INFLAMMATORY MEDIATORS 
(Inflammation is stronger, slower & prolonged) 
 
GRANULATION TISSUE 
 
TISSUE REMODELLING 
(Imbalance in the ratio of MMPs & TISSUE INHIBITORS OF MMPs) 
 
SCAR 
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Types of acne scars
[31]
 
•  Atrophic – Icepick, Boxcar, Rolling, Macular atrophic, 
Perifollicular elastolysis. 
•  Hypertrophic – Keloidal, Papular, Perifollicular fibrosis 
•  Mixed 
•  Unclassified 
Around eighty to ninety percent patients have atrophic scars. Only 
few have hypertrophic scars. 
Goodman and Baron Classification of acne scars
[32] 
Grade 1: Macular - Erythematous, hyperpigmented, or hypopigmented 
marks 
Grade 2: Mild Disease (Mild atrophy) 
Grade 3: Moderate Disease (Moderate scarring) 
Grade 4: Severe Disease - Scarring not flattened with manual stretching 
of the skin.  
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Morphological description of different types of acne scars 
 Ice-pick Scars – They are jagged, deep, very narrow scars that 
 extend into the dermis. They arise from comedones alone. 
 
 
ICE PICK SCARS 
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 Rolling scars– These are shallow and wider than 4–5mm, and they 
appear as superficial shadowing and rolling or undulating 
appearance  to the overlying skin 
 
ROLLING SCARS 
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 Boxcar scars- A round or oval depressions with steep vertical 
sides. 
 
BOX CAR SCARS 
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 Perifollicular electrolysis (PFE) is commonly found on the trunk 
which are multiple, follicular and atrophic. 
 Keloidal scars extend beyond the sites of original inflammation 
and are most prevalent on the trunk. 
 Hypertrophic scars do not extend beyond the extent of the 
original inflammation.  
 
HYPERTROPHIC SCARS 
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Psychosocial effects of Acne and Acne scars 
Patients with moderate to severe acne experience anxiety, shame, 
lack of self confidence, embarrassment, stress and impaired social 
contact. They mayalso face problem of unemployment. There have been 
reports of acne patients committing suicide
[33] 
. 
However it has to be noted that the psychological impairment is 
not always correlated with the severity of lesions. Acne lesions may settle 
down but its sequelae in form of acne scars in some subjects  continue to 
affect their social and emotional well being. Television commercials and 
media further add to their emotional crisis by linking social success with 
cosmetically acceptable lesions. Severalsimple questionnaires have been 
developed to better understand the impact of acne in inducing anxiety, 
depression and impaired quality of life. 
Scarring is also one of the poor prognostic factors in Acne
[34] 
.Many patients continue to get new and severe lesions, making the 
treatment of scarring difficult. Other poor prognostic factors include: 
1) Family History  
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2) Early onset:  Mild  facial comedones. Early and more severe sebum 
production, early onset relative to menarche. 
3) Hyperseborrhoea 
4) Site of acne: Truncal 
5) Persistent 
Although the diagnosis of acne is quiet simple. But following 
differentials must be kept in mind while making the diagnosis as early 
diagnosis and prevention of long term sequelae is important. 
1) Rosacea- Occurs in older patients, absence of comedones, nodules, 
cysts and scarring. There may be facial flushing and specific 
triggers likeheat, spicy food, alcohol. 
2) Perioral dermatitis- Lesions are itchy. Dry skin and absence of 
comedones. There is sparing of the vermillion border. 
3) Milia- May cause confusion with white heads.They are commonly 
seen over infra-orbital region. 
4) Oil acne: Hyperpigmented monomorphic papules, more common 
over extremities and trunk. 
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5) Lupus miliaris disseminates faciei – There is involvement of 
upper eyelid, upper lip. 
6) Drug induced acne- History of drug intake. More widespread. The 
lesions are monomorphic. 
7) Sycosis barbae – Mainly distributed over beard area. It is 
pruritic.Lesion are mainly pustular. 
8) Demodex Folliculitis-   It will be pruritic, absence of comedones, 
demonstration of mites. 
9) Sebaceous hyperplasia- Appears as yellowish papules.There is 
absence of comedones 
10) Angio fibromas-  Skin colored papules  mainly  over nasolabial 
folds. Monomorphic lesions present. 
11) Warts- Flat skin colored to hyperpigmented papules. 
Koebnerization can be seen. 
Acne scarring can mimic scarring due to other underlying conditions like: 
1) Hydroa vacciniforme 
2) Ulerythema ophyrogenes 
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3) Acne keloidalis 
4) Varioliform atrophy 
5) Porphyria cutanea tarda 
Various Syndromes associated with Acne  
1) HAIR-AN Syndrome 
 Hyper Androgenism 
 Insulin Resistance 
 Acanthosis Nigricans 
2) Apert syndrome -  
 Also known as Acrocephalosyndactyly. 
 There is abnormal sensitivity to normal circulating levels of 
androgens. 
 Craniosynostosis and early epiphyseal closure resulting in 
deformities of skull, hands and feet. 
 Severe pustular acne along with other features like seborrhoea, 
hyperhidrosis, dystrophy of nails. 
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3) PAPA Syndrome 
 Pyogenic Arthritis 
 Pyoderma gangrenosum 
 Acne 
4) SAPHO Syndrome  
 Synovitis 
 Acne 
 Pustulosis 
 Hyperostosis 
 Osteitis 
5) Stein Leventhal syndrome 
 It is also known as PCOD ( Poly Cystic  Ovarian Disease). 
 Elevated levels of androgen with absent or infrequent ovulation. 
 Acne, infertility, hyperinsulinemia 
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6) APAAN Syndrome 
 Acne 
 Patterned Alopecia 
 Acanthosis Nigricans 
VARIANTS OF ACNE 
1)  Neonatal acne -Settle spontaneously and leave little in the way of 
scars. 
2) Neonatal Cephalic Pustulosis (NCP) – Presents in first 3 weeks of 
life, characterised by erythematous papular, pustular lesions on 
cheeks, chin, eyelids, neck, upper chest. No comedones seen. Role 
of Malassezia sympodialis and globosa implicated. 
3) Infantile acne - Present later at 3- 6 months of age. Inflammatory 
papules can occur and may result in scarring. 
4) Acne excoriee – In females usually those who keep picking the 
lesions repeatedly. 
5) Senile acne–As a part of Dermatoheliosis i.e. Favre Racouchot 
Syndrome. 
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6) Drug induced- Various drugs can cause acneiform eruption like 
steroids, phenytoin, oral contraceptives. 
7)  Chloracne – Occupational acne caused by exposure to chlorinated 
aromatic hydrocarbons. Multiple comedones usually located on 
both sides of head and neck. 
8) Mechanical acne – acne occurring at the site of physical trauma 
due to repeated mechanical or frictional obstruction of the 
pilosebaceous outlet. 
9) Mallorca acne – Acne lesions specially over upper trunk after 
holiday in a hot, humid environment 
10) Tropical acne- Also known as hydration acne .In those who work 
in hot humid environment. 
11) Acne tarda–Acne in adults. Usually acne subside in early twenties, 
but in some continues in adult life. 
12) Pomade acne – Pomades are greasy preparations used to defrizz 
curly hair. Lesions commonly over the forehead. 
13) Acne conglobate – It’s a severe form of acne. Mulitple 
inflammatory papules, tender nodules and abscesses commonly 
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coalescing to form draining sinuses. It is a difficult to treat 
condition. 
14) Acne fulminans – Acne associated with systemic features like 
fever, polyarthropathy, marked leucocytosis, weight loss, anorexia 
and general malaise. 
15) Pyoderma faciale – Also known as Rosacea Fulminans. Seen 
commonly in context of emotional stress, with sudden eruption of 
many inflammatory pustules and nodules, predominantly over face. 
The lesions are preceded by episode of flushing. 
16) Gram- negative folliculitis – It can occur as a complication of long 
term oral or topical antibiotic therapy to treat acne. Klebsiella, 
Escherichia coli, Serratia marescens, Proteus mirabilis or 
Pseudomonas aeruginosa are implicated. 
17) Detergent acne – Seen in those who wash their face many times 
aday. Trauma and alkalinity of soap may be responsible for 
aggravation of lesions. 
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COMPLICATIONS OF ACNE 
 Scarring 
 Hyperpigmentation 
 Depression, suicidal ideation, anxiety[35] . 
 Psychosomatic symptoms(pain , discomfort) 
 Embarrassment 
 Body dysmorphic disorder 
 Social inhibition. 
 Unemployment[36] . 
TREATMENT OF ACNE 
Because prevention is better than cure, proper and early treatment 
of acne is the first step in the ladder of treatment of acne scars. The aim 
of management is to relieve symptoms, limit disease activity so as to 
prevent new lesions and scarring and negative impact on the quality of 
life. 
42 
 
VARIOUS MODALITIES FOR TREATING ACNE SCARS CAN 
BE GROUPED AS : 
1) Topical therapy 
 Topical antibiotics like Clindamycin, erythromycin- Usually in 
combination with benzoyl peroxide. 
 Benzoyl peroxide – It is a strong antimicrobial. Resistance to it has 
not been reported. Microsponge delivery system helps in controlled and 
targeted delivery of the drug molecule and also reduces the irritancy. 
 Azelaic acid – Dicarboxylic acid with antimicrobial and 
comedolytic property. Also helps in decreasing post acne pigmentation. 
 Topical retinoids – They are comedolytic, anti- inflammatory as 
well as inhibit P. acnes. 
 Dapsone, Nicotinic acid 
2) Oral therapy –  
 Tetracyclines – They are commonly used. They cause a decrease in 
free fatty acids present in sebum, act against P. acnes and are anti- 
inflammatory. 
 Macrolides – Erythromycin  and  Azithromycin are used. 
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 Retinoids–Isotretinoin use has revolutionized the anti-acne therapy. 
Mechanism of action of retinoids: 
 Decreases seborrhoea 
 Comedolytic 
 Inhibits P. acnes 
 Anti- inflammatory 
 Others - Trimethoprim-sulphamethoxazole, Clindamycin, Dapsone 
3) Hormonal therapy- Oral contraceptives, Antiandrogens, 
Gonadotropin releasing hormone  agonists. 
4) Physical modalities-  
 Phototherapy – UV light, Photodynamic Therapy 
 Lasers – Pulsed potassium titanyl phosphate laser ( 532 nm)1320 
nm Nd- YAG Laser,1540 Erbium glass laser. 
5) Newer therapies – 
 Green Tea- Anti-inflammatory and interferes with IGF-1 signalling 
thereby reducing sebum production.    
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GLOBAL ALLIANCE ALGORITHM FOR IMPROVING OUTCOME IN ACNE
[37] 
 MILD MODERATE SEVERE 
COMEDONAL PAPULAR/PUSTULAR PAPULAR/PUSTULAR NODULAR NODULAR/CONGLOBATE 
1
st
 choice Topical retinoid Topical retinoid + topical 
antimicrobial 
Oral antibiotic + topical 
retinoid +/-  BPO 
Oral antibiotic + topical 
retinoid +/- BPO 
Oral Isotretinoin 
Alternatives Alt. topical retinoid 
or azelaic acid or 
salicylic acid 
Alt. topical antimicrobial 
+ alt. topical retinoid 
Alt. oral antibiotic + alt. 
topical retinoid +/- BPO 
Oral isotretinoin or alt. oral 
antibiotic + alternate topical 
retinoid+/- BPO / Azelaic acid 
High dose oral 
antibiotic+topical retinoid + 
BPO 
Alternatives 
for females 
See 1
st
 choice See 1
st
 choice Oral antiandrogen + 
topical retinoid + 
/azelaic acid  
+/- topical antimicrobial 
Oral antiandrogen + topical 
retinoid +/- oral antibiotic +/- 
alt. anti microbial 
High dose oral antiandrogen + 
topical retinoid +/- topical 
antimicrobial 
Maintenance 
therapy 
Topical retinoid Topical retinoid+/- BPO    
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Various procedures used for acne scars are : 
1) Chemical peels/ CROSS (chemical reconstruction of  skin scars) 
2) Subcision 
3) Dermabrasion 
4) Microdermabrasion 
5) Laser resurfacing 
6) Punch elevation and excision 
7) Skin needling 
8) PRP  
9) Fillers 
Scar excision  
Tiny/minute, well defined scars can be removed by punch excision, 
elevation, subscision. 
  
46 
 
 
 Punch excision - The scar is excised with a punch and the skin is 
sutured together                   
 
 Punch elevation - Punch of appropriate size is inserted in to the 
scar till base and adhesions at sides are cut, the plug is then raised. 
This procedure is called punch elevation 
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 Punch excision and grafting-Scars are removed with a punch and 
is replaced by donor graft from retroauricular area 
 
 
 Subcision - Surgically freeing up the deeper layers of the skin so 
the scars are no longer bound down. A needle or surgical scissors 
are used to physically separate the dermis and subcutaneous tissue. 
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 Microdermabrasion – Skin resurfacing with Aluminium oxide or 
sodium chloride microcrystals to superficially remove stratum 
corneum and epidermis. 
 Dermabrasion: Involves the controlled deeper abrasion of the 
upper tomid layers of the skin with a strong abrasive devices 
including a wire brush, diamond wheel or fraise, sterilized sand 
paper, salt crystals, or  other mechanical means. 
 Microneedling: Involves repeatedly puncturing the skin with tiny, 
sterile needles (microneedling the skin) in order to induce 
endogenous production of cutaneous collagen. 
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 Chemical peeling – Exfoliation  of skin induced by the use of 
chemical cauterant or escharotics agent on the skin 
Peels used commonly 
 TCA 
 Alpha hydroxyl acids  -glycolic acid 
 Salicylic acid 
 Retinoic acid 
 Jessner’s solution 
 Phenol 
 5 – Fluorouracil 
 Alpha keto acid 
Types of Chemical peels 
 Very superficial- glycolic acid 10 to 30%, TCA 10%, Jessner’s 
solution 
 Superficial- glycolic 50 to 70%,TCA 10 to 35% 
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 Medium depth – glycolic >70%, TCA 35 to 50% 
 Deep – phenol 88% 
TCA CROSS –focal application of higher concentrations of 
trichloroacetic acid (TCA) and is pressed hard on the entire depressed 
area of atrophic acne scars. This technique is called chemical 
reconstruction of skin scars (CROSS) 
Laser – CO2 Laser is used which has a wavelength of 10600 
nm.Resurfacing of acne scars done by sculpturing the edges.  
Fillers- Purified bovine  collagen is injected in the defective areas. 
Now degradable, synthetic implants like hyaluronic acid  are used, 
to avoid risks   of sensitizations & foreign body reaction. 
Freeze dried, radiation treated fascia lata from human cadaver 
implant is placed at site of each scar by creating an intradermal pocket at 
site with help a needle. Alternate method is autologus fat transplantation 
to acne scars. 
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Most of the procedures mentioned above have been used over 
years for the treatment of acne scars. However most of them have one or 
more drawbacks like : 
 Risk of hyperpigmentation  
 Keloid formation 
 Cost factor 
 Some procedures have long downtime. 
There is a need to find simpler, safer and effective means to add to this 
list of procedures which can be used either alone or in combination with 
the above methods to provide satisfactory results to the patients. 
PLATELET RICH PLASMA 
COMPONENTS OF BLOOD: 
Blood consists of Red blood cells, White blood cells, Platelets and 
Plasma. 
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Plasma: 
 Relatively clear, yellow tinted 
 Constitutes 55% of the blood volume. 
 Carries RBCs, WBCs and platelets. 
 Contains various hormones, enzymes, proteins and antibodies. 
Red Blood Cells: 
 Large microscopic cells without nuclei.  
 They normally make 40- 50% of total blood volume.  
 Main role is oxygenation of tissues. 
White Blood Cells: 
 Constitute 1% of total blood volume 
 Component of body’s defence mechanism. 
 Neutrophils, eosinophils, basophils, monocytes, lymphocytes. 
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Platelets: 
 Cytoplasmic fragments of megakaryocytes (a type of white blood 
cell), which are produced in the bone marrow. 
 Round or oval inshape, approximately 2 mm in diameter.  
 Platelets do not have nuclei but contain organelles and structures 
such as mitochondria, microtubules, and granules ( α, δ, λ).  
The α granules contain around 30 bioactive proteins which play a 
role in hemostasis and tissue healing.  
In PRP therapy the basic objective is applying supra-
pharmacological dose of platelets directly at the site where tissue 
regeneration is required. 
PRP therapy is being used in other medical fields but it is new in 
dermatology. 
It helps to rejuvenate & regenerate injured tissues and also 
modulates wound healing. 
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DEFINITION OF PRP 
Platelet-rich plasma (PRP), also called as  autologous platelet gel 
or plasma-rich growth factors and platelet-concentrated plasma means 
“abundant platelets that are concentrated into a small volume of 
plasma.”[38] 
The discovery of platelet-derived growth factor (PDGF) in 
promoting wound healing, angiogenesis and tissue remodelling threw 
light on this novel autologous therapeutic modality. This mixtures of GFs 
plays pivotal role in modulation of tissue repair and regeneration
[39] 
. 
Degranulation of the pre-packaged GFs in platelets occurs upon 
“activation” i.e.on coming in contact with coagulation triggers.  
The secreted GFs in turn bind to their respective transmembrane 
receptors expressed over adult mesenchymal stem cells, osteoblasts, 
fibroblasts, endothelial cells, and epidermal cells.  
This further induces an internal signal-transduction pathway, 
unlocking the expression of a normal gene sequence of a cell like cellular 
proliferation, matrix formation, osteoid production, collagen synthesis, 
etc., thereby augmenting the natural wound-healing process. 
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CELL RATIO IN NORMAL BLOOD 
RBCs
WBCs
PLATELETS
CELL RATIOS IN PRP 
RBCs
WBCs
PLATELETS
RBCs 
93% 
PLATELETS 
94% 
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HISTORY OF PRP 
PRP has been therapeutically used to accelerate woundhealing and 
tissue repair in dentistry since 1998, and theclinical application of PRP 
was recently expanded to other fields, including cardiac surgery, 
ophthalmology, oral and maxillofacial surgery, orthopedic surgery, 
plastic surgery, sports medicine, and cosmetic medicine.
[40]
Different ways 
of preparing PRP have come into existence : from conventional blood 
centrifugationto commercial systems; activated by adding collagen, 
calcium and/or thrombin, by glass contact orby freezing cycles; applied 
as platelet suspension or as agel; and the methodology still continues to 
broaden. 
 It is a biological product which is being prepared using different 
protocols. The injection of platelet-derived factor into a tissue appears to 
trigger the ound healing process without any actual wounding. It is 
believed that PRP induces local tissue re –modelling and angiogenesis by 
activating tissue-resident progenitor/stem cells and may also recruit bone-
marrow-derived progenitor/stemcells. 
For  preparing PRP , two methods have been explained depending 
upon the number of centrifugation steps used: one is the single spin 
method and the other is double spin method. Double spin method has 
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been shown to be better yielding than the single spin method
[41] 
.The first 
centrifugation is slow to avoid spinning down platelets, whereas the 
second spin is fast, so the platelets are spun down and can be collected 
easily for various therapeutic indications. 
After preparation, platelet-rich plasma is stable, in the anti-
coagulated state, for 8 hours
[42] 
.The platelet-rich plasma must be 
activated for the platelets to release their alpha granule content. 
PRP is prepared in a day care setting just prior to the procedure. 
The process must be carried out under strict aseptic conditions as well as 
optimum temperature regulations i.e.20-22°C. In order to inhibit platelet 
aggregation, it is prepared with an anticoagulant, commonly using 
anticoagulant citrate dextrose solution formula A (ACD-A) 
[43]
 or sodium 
citrate. The platelets need to be sequestered in high concentrations, 
enough for achieving therapeutic benefit and in a viable state at the same 
time, so that they can actively secrete their GFs. 
So this modern technology allows us to concentrate platelets and 
white blood cells from a patient’s blood and to induce the release of 
growth factors by injecting the solution directly into injured tissue, 
stimulating the same healing process but in a more directed form. 
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Various growth factors present in PRP are –  
1) Transforming growth factor beta (TGF) β1 – mediates 
angiogenesis.TGFβ 2- Acts as chemotactic for fibroblasts, keratinocytes 
and macrophages. It is also mitogenic for smooth muscle cells and 
fibroblasts. It also has potential to regulate matrix proteins, collagen and  
proteoglycans. 
2) Platelet derived growth factor (PDGF) αα –It is chemotactic for 
fibroblasts and macrophages. PDGF ββ and αβ – They are mitogenic for 
fibroblasts, smooth muscle cells and endothelial cells. 
3) Vascular Endothelial Growth Factor (VEGF)- Chemotactic and 
mitogenic  for endothelial cells. 
4) Epidermal growth factor – It is mitogenic for fibroblasts, 
keratinocytes and endothelial cells. 
5) Fibroblast growth factor-2 (FGF-2)- It has a role in tissue 
organization and regeneration. 
6) Fibroblast growth factor 9- Helps in regeneration of hair follicle.  
7) Hepatocyte growth factor – Helps in regeneration. 
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PRP PREPARATION BY MANUAL DOUBLE SPIN 
METHOD
[44] 
According to The American Association of Blood Banks technical 
manual, first the  ‘platelet-rich plasma’ is separated from whole blood by 
‘soft or light-spin’ centrifugation and subsequently the platelets are 
concentrated by ‘ hard or heavy-spin’ centrifugation . After which the 
supernatant plasma is removed. The basic principle behind the PRP 
separation procedure is as follows: Different blood components have 
different specific gravities. So on centrifugation they get separated into 
different layers. 
As the Red blood cells are heaviest they settle at the bottom, 
followed by white blood cells and the top layer is of platelets as they are 
lightest. In the first step aim is to separate the plasma from rest of the 
components. This is done by a slow centrifuge, after which platelets get 
concentrated just above the buffy coat. In the later step, centrifugation is 
faster so that platelets get concentrated and settle down at the bottom of 
the test tube.  
Approximately 3/4 of the supernatant is discarded and the platelet-
rich pellet is re-suspended in remaining amount of plasma. Calcium 
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chloride (CaCl2) or thrombin is then added as an “activator” to activate 
the platelets and hence degranulation of GFs to yield “activated PRP”. 
Maximum secretion of the growth factors occur within ten minutes 
of activation, so the activated PRP must be used as early as possible. 
There is variability in the yield of platelets obtained depending 
upon the methods used, rate and time of spin, anticoagulant used and 
even the size and shape of container. The platelet yields may vary from 4 
to 7 times the baseline. To assure the viability of platelets the temperature 
should be maintained between 20- 22 degree centigrade. Trypan blue 
staining can  be used  to confirm the viability. 
Double spin method is used preferably over single spin method, as 
studies have shown that the single spin method failed to achieve the 
therapeutic levels of platelet .As there are different protocols, devices and 
centrifuge speeds for preparing PRP, so different types of platelet 
concentrates are obtained.  It was Ehrenfest et al who first proposed a 
classification for the  platelet concentrate
[45] 
. 
He classified them into four types depending upon the leucocyte 
and fibrin content: 
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1) P-PRP (Pure Platelet Rich Plasma) - This can be prepared by 
collecting only the buffy coat alone after the first soft spin. Very 
few leucocytes will be present. 
2) L-PRP( Leucocyte  and Platelet Rich Plasma ) – This type 
contains mostly platelets with few but appreciable amount of 
leucocytes. There is difference in collection of PRP. After soft 
spin, plasma, buffy coat and topmost layer of RBC is harvested. 
Later after hard spin lowest fraction of product  is harvested which 
contains all platelets and few leucocytes. 
3) P-PRF (Pure Platelet Rich Fibrin) –This is obtained by mixing  
PRP with activator and incubating it for some time so that a stable 
platelet rich fibrin clot is formed . 
4) L-PRF (Leucocyte and Platelet Rich Fibrin) – In this no 
anticoagulant added and no activator required. First blood is 
collected without any anticoagulant  and centrifuged without delay. 
The process results in three layers. L-PRF layer is formed in 
middle and harvested. 
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CONCENTRATION OF PLATELETS IN PRP 
The average concentration of platelets in blood is 200,000 ± 
75,000/μL. For a preparation to be labelled as PLATELET RICH, the 
concentration of platelets should rise to level of five to ten times the base 
line
[46] 
. 
 Now a days in market, various automated devices are available for 
preparing PRP. However these devices are expensive than manual 
methods and the commercial interest of the manufacturers can deteriorate 
the quality of platelet concentrates. 
INDICATIONS OF PRP IN DERMATOLOGY  
1) Androgenetic Alopecia–PRP has been used as incubation medium 
in Follicular Unit Transplant as well as Mesotherapy
[47]-[48]
 . 
2) Alopecia areata – Significant hair growth has been seen in other 
alopecias like alopecia areata and telogen effluvium 
[49] 
. 
3) Skin rejuvenation – PRP has become very popular in asthetic 
medicine. It is shown to remove photo damaged extra cellular 
matrix and induce synthesis of new collagen. PRP can be applied 
topically under occlusion or given as intradermal injections 
[50]-[55] 
 . 
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4) Acne scars and contour defects–PRP has been used as 
mesotherapy alone or in combination with other modalities like 
dermaroller or laser resurfacing 
[56]-[60]
 . 
5) Wound ulcers and connective tissue disease associatedulcers- 
Stasis ulcers, trophic ulcers, diabetic ulcers and traumatic ulcers 
have shown good healing after treatment with PRP 
[61]-[63] 
. 
6) Striae distensae[64]-[65] -  Kim et al used an intradermal radio-
frequency device which delivered higher energy fluencies directly 
to the dermis, along with injecting PRP as a filler through its needle 
electrode. 
7) Lipodermatosclerosus[66] – There is a single case report in which  
five  sessions of PRP led to complete healing of venous ulcer and 
marked improvement in the pigmentation and induration. 
8) Lichen Sclerosus[67]  -PRP along with autologous fat transfer  is  a 
novel technique in management of lichen sclerosus of vulva. 
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SAFETY OF PRP 
Autologous PRP is quite safe. The mitogenic effect of PRP is 
limited tothe normal healing process. PRP is not mutagenic as whatever 
growthfactors it delivers, act through signal transduction only
[68]
 .These 
growth factors do not enter the cells or nucleus .There may be local 
injection site reactions like  transient erythema or Pain. Secondary 
infection is rare when the procedure is carried out under strict septic 
precautions. Since PRP is autologous,  there is no risk of transmission of 
Hepatitis B, C or   HIV.  
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AIM AND OBJECTIVE OF THE STUDY 
 
 To assess efficacy and safety of PLATELET RICH 
PLASMA (PRP) for treatment of acne scars. 
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Study design  
 Type of study – Non randomized Prospective Interventional study 
Study population 
 Sample size – forty patients  
Study period 
 JUNE  2013 to MAY 2014 
Place of study 
 Department of Dermatology, 
Government Stanley Medical College & Hospital 
Chennai. 
A brief and relevant medical history and physical examination 
(Annexure 1) was done at screening visit to ensure relevant eligibility 
criteria. Patients were elaborately explained about the procedure and 
consent was taken. Then the patient thoroughly evaluated and grading of 
acne scars (Goodman and Baron Classification of acne scars) done. 
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Patient were explained about PRP therapy, benefits of therapy, possible 
side effects and prognosis of treatment. 
Informed consent was taken. Digital photographs of face taken. 
        Platelet-rich plasma was injected by multiple tiny punctures under 
the dermis, with or without topical local anesthesia. Up to 6 sittings were 
given within a 6-month time frame. Either the patient improved to grade 
1 or a maximum of 6 sittings, whichever was earlier. These were 
performed  4 weeks apart. At the end of treatment duration, scars were 
graded using grading system as used in the beginning, photographs taken 
and compared. 
PRE-TREATMENT CONSULTATION 
• Patients were well informed about the procedure and the possible 
side effects. 
• Informed and written consent were obtained 
• Complete history regarding onset, duration, any other co-existing 
systemic illness, past history of any treatment for the same, Isotretinoin 
use, immunosuppressive agents, Hepatitis B co-infection were also noted. 
•  Proper Counselling of patient is very important.  
• The motivation of the patient is assessed. 
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INCLUSION CRITERIA:  
• Both sexes 
• Age >18 years  
• Atrophic Acne scars – rolling and boxcar  scars   
• Patient willing for follow up and to be  photographed. 
 EXCLUSION CRITERIA: 
• Active nodulocystic acne. 
• Keloidal tendency. 
• Bleeding disorder. 
• Oral steroids. 
• Anticoagulant therapy. 
• Any active skin infection. 
• Pregnancy 
• Skin diseases like SLE, porphyrias 
• Metabolic and systemic disorders. 
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• Patients who received Oral Isotretinoin for acne during last one  
month 
PRE PROCEDURE WORK UP 
• Hb, TC, DC, ESR, Platelet count 
• Bleeding time, clotting time 
• Fasting blood glucose 
• Renal function test – blood urea, serum creatinine 
• SGOT 
• SGPT 
• Screening for Hepatitis B, HIV, VDRL testing. 
• Informed consent and photographs 
GRADING OF ACNE SCARS 
The grading of acne scars was done according to the following 
scale (Goodman and Baron Classification of acne scars) 
 GRADE 1- Macular-Erythematous, hyper- or hypopigmented flat 
marks. No problem of contour like other scar grades. 
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GRADE 2- Mild- Mild atrophic scars that may not be obvious at social 
distances of >/= 50 cm and may be covered adequately by makeup or the 
normal shadow of shaved beard hair in men. 
GRADE 3- Moderate- Moderate atrophic scarring that is obvious at 
social distances >/= 50cm and is not covered easily by makeup or the 
normal shadow of shaved beard hair in men, but is still able to be 
flattened by manual stretching of the skin 
GRADE 4-Severe-Severe atrophic scarring that is evident at social 
distances >50 cm and is not covered easily by makeup or the normal 
shadow of shaved beard hair in men and is not able to be flattened by 
manual stretching of the skin. 
INSTRUMENTS AND MATERIALS REQUIRED 
Centrifuge machine 
Sterile test tubes 
Sterile pipettes 
Sterile bowls 
Anticoagulant Acid citrate dextrose 
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10% calcium chloride as activator 
Topical numbing cream 
Insulin syringe  
Sterile gauze 
PRP PREPARATION 
Full process is carried out under strict aseptic conditions. Room 
temperature maintained at 22- 26 degree centigrade. 
10 ml blood is collected from the patient in the centrifuge test tubes 
(labelled with patient’s name and age) and mixed with anticoagulant 
ACD (Acid Citrate dextrose ) in the ratio of 10: 1.5 . 
The tube is then placed for first centrifugation i.e. soft spin at the 
rpm of 2000 for ten minutes. At the end of this plasma gets separated and 
we pipette out plasma, buffy coat and uppermost layer of red blood cells 
into another tube. The uppermost layer of RBCs are collected because it 
has been shown that a portion of young platelets is present in this layer . 
This collected part is again subjected to second centrifugation .This 
is hard spin at the rpm of 3000 for another ten minutes . At the end of this 
step, platelets settle down at the bottom of the test tube . The upper three- 
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fourth of supernatant is discarded without disturbing the lower layer and 
lowest portion obtained is the Platelet Rich Plasma. PRP is now ready for 
the use. It should be activated just before injection into skin by adding 10 
% calcium chloride to it in the ratio of 1: 10 (1 part CaCl2, 10 parts PRP) 
and agitating it by vigorous shaking. 
10 ml Blood collected from the patient 
 
ACD added to it in the ratio of 10: 1.5 ( 10 parts BLOOD: 1.5 part ACD) 
 
First centrifuge at the rate of 2000 rpm for 10 min 
 
Separate the plasma, buffy coat and upper layer of RBCs and discard rest 
 
Second centrifuge at the rate of 3000 rpm for 10 min 
 
Now collect the lower 2.5 ml and discard the supernatant  
 
PRP prepared is activated by adding 10% CaCl2( 10: 1) 
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PROCEDURE PROPER 
 The area to be treated is anaesthetized with topical anasethesia like 
EMLA ( Eutectic mixture of lidocaine and prilocaine). 
 10 ml of blood is drawn from the patient, which is used for 
preparation of Platelet Rich Plasma according to the procedure 
mentioned above and under strict aseptic precautions. 
 After about 45 minutes the area to be treated is cleaned with spirit. 
Skin is stretched and the Activated PRP is loaded in insulin syringe 
and injected into the scars and around it through multiple 
punctures. 
 Mild erythema can be seen immediately after the procedure. Face 
is wiped with a mild cleanser. Patient advised not to vigorously rub 
the face for 12 hours and not to take aspirin or other  
anti- inflammatory drugs while on therapy. 
 No dressing is required. No other specific instruction. 
 The same procedure is carried at interval of every 4 weeks for 6 
months. 
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 At every visit clinical grading is done, patient satisfaction assessed 
and clinical photograph taken.  
The procedure was continued until either the grading of scars 
became 1 or upto maximum of 6 sittings, whichever came first. 
Patients’ satisfaction was accounted at the end of the sittings according 
to following scale: 
SCORE PATIENT’S SATISFACTION 
0 POOR 
1 FAIR 
2 GOOD 
3 VERY GOOD 
4 EXCELLENT 
 
Dermatology Life Quotient Index( DLQI) was calculated before 
and after the completion of the treatment using the following 
questionnaire : 
1. Over the last week, how itchy, sore, painful or stinging has your 
skin been? 
2.  Over the last week, how embarrassed or self  conscious have you 
been because of your skin? 
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3. Over the last week, how much has your skin interfered with you 
going shopping or looking after your home or garden? 
4.  Over the last week, how much has your skin influenced the clothes 
you wear? 
5.  Over the last week, how much has your skin affected any social or 
leisure activities? 
6.  Over the last week, how much has your skin made it difficult for 
you to do any sport? 
7.  Over the last week, has your skin prevented you from working or 
studying? 
If  “No”, over the last week how much has your skin been a problem 
at work or studying? 
8.  Over the last week, how much has your skin created problems with 
your partner or any of your closefriends or relatives? 
9.  Over the last week, how much has your skin caused any sexual 
difficulties? 
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10.  Over the last week, how much of a problem has the treatment for 
your skin been, for example, by making your home messy, or by 
taking up time? 
DERMATOLOGY LIFE QUALITY INDEX was calculated as following  
before and after the treatment. 
0-1 = no effect at all on patient's life  
2-5 = small effect on patient's life 
6-10 = moderate effect on patient's life  
11-20 = very large effect on patient's life  
21-31 = extremely large effect on patient's life. 
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Study population  
This study included total 40 patients 30 male and 10 female 
patients. 
Youngest age is 18 years of age and oldest is 31 years of age. All 
fulfilled the inclusion and exclusion criteria 
TABLE 1 – AGE WISE DISTRIBUTION OF STUDY 
POPULATION 
Age group Number of patients 
<20 2 
20 to 25 20 
26 to 30 16 
>31 2 
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CHART NO. 1:       AGE WISE DISTRIBUTION OF    
                  STUDY POPULATION 
< 20 years-  2
20- 25 years- 20
26 - 30 years- 16
>31 years- 2
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SEX WISE DISTRIBUTION OF STUDY POPULATION 
 
Males Females 
30 10 
 
 
 
 
 
Sex-wise distribution of study population 
MALES - 30
FEMALES - 10
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TYPE OF ACNE SCARS INCLUDED IN THE STUDY 
 
Type of scar Number of patients 
Rolling 18 
Boxcar scar 8 
Both boxcar and rolling 14 
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After 3 sittings of the procedure appreciable changes were seen on 
the skin surface of most of the patients. 
At every visit, the treated area over patient’s face was 
photographed and compared with the previous visit photograph and 
grading was done according to the scale mentioned above. In most of the 
cases the depth of scars was reduced making the scars less obvious than 
before.
NO. OF PATIENTS IN DIFFERENT TYPES  
OF SCARS 
Rolling scars
Box car scars
Both rolling and box car
18% 
8% 
14% 
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ASSESSMENT OF IMPROVEMENT AT THE END OF 4 WEEKS AFTER EACH SITTING 
S. 
No. 
NAME 
AGE 
& 
SEX 
INITIA
L 
GRADE 
GRADING AT THE END OF 
Comment 1
ST
 
Sitting 
2
ND
 
Sitting 
3
RD
 
Sitting 
4
TH
 
Sitting 
5
TH
 
Sitting 
6
TH
 
Sitting 
1. Arul  21/M 3 3 3 2 1   3 → 1 
2. David 28/M 4 4 4 3 3 2 2 4 → 2 
3. Shama 25/F 4 4 4 4 3 2 2 4 → 2 
4. Satya 28/M 3 3 3 2 2 2 2 3 → 2 
5. Anitha 29/F 3 3 3 2 2 2 2 3 → 2 
6. Shiva  24/M 2 2 2 2 2 2 2 No change in grade, but 
depth improved. 
7. Aiysha 26/F 2 2 2 2 1   2→1 
8. Priya 21/F 3 3 3 3 3 3 3 No improvement 
9. Akash 25/M 3 3 3 2 2 2 2 3 → 2 
10. Suresh  33/M 4 4 3 2 2 2 2 4 → 2 
11. Vinay 22/M 4 4 3 2 2 2 2 4 → 2 
12. Ramya 20/F 2 2 2 2 2 2 2 No change in grade, but 
depth improved 
13. Karthik 19/M 4 4 4 3 3 2 2 4 → 2 
14. Dinesh  27/M 4 4 4 4 3 2 2 4 → 2 
15. 
 
 
 
 
 
Praveen  27/M 3 3 3 2 2 1  
 
3 → 1 
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S. 
No. 
NAME 
AGE 
& 
SEX 
INITIA
L 
GRADE 
GRADING AT THE END OF 
Comment 1
ST
 
Sitting 
2
ND
 
Sitting 
3
RD
 
Sitting 
4
TH
 
Sitting 
5
TH
 
Sitting 
6
TH
 
Sitting 
16. Stephen  19/M 2 2 2 2 2 2 2 No change in grade, but 
depth  improved. 
17. Swati  28/F 4 4 4 3 2 2 2 4 → 2 
18. Aasif 25/M 3 3 3 3 3 3 3 No improvement 
19. Karthikeyen 26/M 3 3 3 2 2 2 2 3 → 2 
20. Sarvanan 22/M 4 4 4 4 4 4 4 No improvement 
21. Sekar 21/M 3 3 3 2 2 2 2 3 → 2 
22. Yuvraj 28/M 3 3 3 2 2 2 2 3 → 2 
23. Kavitha 25/F 3 3 3 2 2 2 2 3 → 2 
24. Santosh 29/M 4 4 4 4 4 4 4 No change in grade, but 
depth improved 
25. Murugan 28/M 4 4 4 4 3 3 3 4 → 3 
26. Prasanth 26/M 3 3 3 2 1   3 → 1  
27. Govind 23/M 3 3 3 2 2 2 2 3 → 2 
28. Shwetha 25/F 3 3 3 2 2 2 2 3 → 2 
29. Senthil 27/M 4 4 4 3 3 2 2 4 → 2 
30. Kumar 21/M 3 3 3 3 2 2 2 3 → 2 
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S. 
No. 
NAME 
AGE 
& 
SEX 
INITIA
L 
GRADE 
GRADING AT THE END OF 
Comment 1
ST
 
Sitting 
2
ND
 
Sitting 
3
RD
 
Sitting 
4
TH
 
Sitting 
5
TH
 
Sitting 
6
TH
 
Sitting 
31. Vijay 21/M 2 2 2 2 2 2 2 No change in grade, but 
depth improved 
32. Rajsekar 23/M 3 3 3 2 2 1  3 → 1 
33. Selvam 26/M 4 4 4 4 4 4 4 No change in grade , but 
depth improved 
34. Arunraj 25/M 3 3 3 3 2 2 2 3 → 2 
35. Vinayak 29/M 4 4 4 3 3 2 2 4 → 2 
36. Bhaskar 24/M 3 3 3 2 2 2 2 3 → 2 
37. Keerthi 26/F 4 4 4 3 2 2 2 4 → 2 
38. Sohail 32/M 4 4 4 3 2 2 2 4 → 2 
39. Balaji 20/M 3 3 3 2 2 2 2 3 → 2 
40. Ilakiya 25/F 4 4 4 3 2 2 2 4 → 2 
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MINIMUM NO. OF SITTING 
REQUIRED TO PRODUCE 
IMPROVEMENT BY GRADE  
1 OR MORE 
NO. OF PATIENTS 
1 0 
2 2 
3 23 
4 6 
5 0 
6 0 
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0
5
10
15
20
25
1st Sitting 2nd Sitting  3rd Sitting 4th Sitting 5th Sitting 6th Sitting
MINIMUM NO. OF SITTINGS REQUIRED TO 
PRODUCE IMPROVEMENT BY ATLEAST 1 
GRADE 
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Based on all the above observations, final improvement in patients 
was graded as following: 
IMPROVEMENT IN GRADE NO. OF PATIENTS 
NO IMPROVEMENT 3 
MILD( improvement was seen but 
difficult to say that grade changed) 
6 
MODERATE 
( those who decreased by  1 grade) 
14 
MARKED (those who attained grade1 
or decreased by 2 grades) 
17 
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FINAL IMPROVEMENT IN ACNE GRADE 
NO
MILD
MODERATE
MARKED
7.5% 
15% 
35% 
42.5% 
89 
 
 
 
The mean DLQI improved by 61.13%. 
At every visit patient was also asked about his satisfaction and 
whether he can appreciate any change. At the end of two months after 6 
sittings of the procedure, final grading of acne scars done and the 
patient’s satisfaction score was graded as below:  
  
0
5
10
15
20
25
Mean DLQI before treatment Mean DLQI after treatment
COMPARISON OF DLQI BEFORE AND AFTER THE 
TREATMENT 
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PATIENT’S 
SATISFACTIONSCORE 
NO. OF PATIENTS 
Poor- 0 3 
Fair- 1 5 
Good -2 21 
 Very good - 3 11 
Excellent - 4 0 
 
The patients were followed up monthly for a period of 6 months 
after the procedure to look for any complications and also to make sure 
that the results were not transient. 
There were no drop outs in the study. All 40 patients continued 
with the procedure till the end. 
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PATIENT'S SATISFACTION SCORE 
POOR
FAIR
GOOD
VERY GOOD
52.5% 
27.5% 
7.5%
% 
12.5% 
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COMPLICATIONS: 
Practically the only complication seen was immediate post 
procedure erythema, which was seen in all the patients. The erythema 
however was transient  and resolved in 6- 12 hours. 
Even after proper application of topical numbing cream, around 5 
patients complained of mild discomfort during the procedure. 
Apart from these, no other complication was noted. 
TABLE 4: COMPLICATIONS 
Complications Number of patients 
Post procedure erythema 40 
Pain 5 
Secondary infection 0 
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CENTRIFUGE  MACHINE 
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COLLECTION OF BLOOD FROM THE PATEINT 
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AFTER SOFT SPIN, SEPERATION OF PLASMA,  
BUFFY COAT AND RBCs 
 
   
AFTER HARD SPIN PLATELETS SETTLE AT BOTTOM 
 
Plasma 
Buffy Coat 
RBCs 
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PRP INJECTIONS INTO THE AREA TO BE TREATED 
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PRE- TREATMENT PHOTOGRAPH 
 
AFTER 4 SITTINGS OF PRP MARKED IMPROVEMENT 
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PRE TREATMNENT PHTOGRAPH 
 
AFTER 6 SITTINGS OF PRP MARKED IMPROVEMENT 
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SAME PATIENT 6 MONTHS POST TREATMENT, 
EFFECT IS MAINTAINED 
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PRE TREATMENT PHOTOGRAPH 
 
AFTER 6 SITTINGS OF PRP MARKED IMPROVEMENT 
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PRE TREATMENT PHOTOGRAPH 
 
AFTER 6 SITTINGS OF PRP MARKED IMPROVEMENT  
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SAME PATIENT 6 MONTHS POST 
TREATMENT, EFFECT IS MAINTAINED 
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PRE TREATMENT PHOTOGRAPH 
 
AFTER 6 SITTINGS OF PRP MILD IMPROVEMENT 
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PRE TREATMENT PHOTOGRAPH 
 
AFTER 6 SITTINGS OF PRP MODERATE 
IMPROVEMENT 
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PRP is a novel approach in the management of atrophic acne scars. 
The results are comparable with other approaches for acne scars if used 
singly. Out of 40 patients, 42.5 % patients(17) showed  marked 
improvement in the grading of acne scars. It means they improved upto 
grade 1 OR there was an improvement by 2 grades. 35% patients (14) 
showed moderate improvement. In these patients grading of acne scar 
improved by 1.  In 15% (6) patient although the grading did not change 
but there was visible improvement in appearance of the scars. In only 
7.5% patients(3), no improvement was seen even after 6 sittings of PRP, 
who were definitely candidates for combination with other modalities. 
Among the patients who showed improvement, 57.5% patients 
showed this improvement after 3
rd
 sitting. In 15%, first improvement was 
seen at 4
th
 sitting.  In a small group of patients (5%), the effect could be 
appreciated at the end of 2
nd
 sitting itself. 
Around 52.5% patients put their satisfaction score as ‘good’at the 
end of procedure, while 27.5 % patients scored it as‘very good’. 12.5% 
patients gave a score of ‘fair’. Only 7.5% gave a ‘poor’ score. 
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The mean DLQI of the patients changed from 22.9 before 
treatment to 8.9 after treatment (61.13% improvement) . 
Complications seen were only in form of transient erythema and 
pain. A follow up period upto 6 months showed that the results were 
permanent and there were no complications. 
Most of the studies available have combined platelet rich plasma 
with conventional treatment for acne scars. However the individual effect 
of PRP has not been studied extensively. 
The purpose of this study was to see the individual role of platelet 
rich plasma in the treatment of acne scars. 
In a study done by Jiang  Ting  Zhu  et al
[69]
 ,combining  Erbium 
Fractional LASER with PRP, 90.9% of the patients showed an 
improvement of >50%, and 91% of the patients were satisfied. However 
this study could not precisely tell about the role of PRP alone in 
remodelling of tissues. 
Lee et al conducted a split-face trial that treated acne scars with 
PRP following ablative CO2 fractional resurfacing
[60]
. Fourteen Korean 
participants with acne scars were included in this study. They received 
one session of ablative CO2 fractional resurfacing, and then facial halves 
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were randomly assigned to receive treatment with autologous PRP 
injections on one side (experimental side) and normal saline injections on 
the other side (control side). Erythema edema on the experimental side 
improved faster than on the control side, and overall degree of clinical 
improvement was significantly better on the experimental side than on the 
control side.  
Another study was done by Alessio Redaelli et al on Face & Neck 
revitalization using PRP alone
[53]
, showed that PRP is a easy to perform 
& promising technique in face & neck revitalization & scar attenuation. 
Patients were treated with 3 sessions of PRP injections alone at interval of 
4 weeks. A photograph score, patient’s satisfaction score and doctor’s 
satisfaction score all together showed an overall satisfactory result. 
In a study Combining Use of Skin Needling and Platelet-Rich 
Plasma in Acne Scarring Treatment by Gabriella Fabbrocini et al
[70]
, it 
was shown that the combined use of skin needling and PRP is more 
effective in improving acne scars than skin needling alone. The study 
showed that the microneedling apart from inducing new collagen 
synthesis made the  PRP penetration easier, which helped in the action of 
the growth factors present in the PRP. 
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In our study, instead of using microneedling technique, PRP was 
directly injected into acne scars. 
Bouwer et al also studied the effects of PRP mesotherapy in skin 
rejuvenation and scar attenuation.
[71]
 They reported a very high 60% 
improvement in post acne scar with two sitting of  PRP alone, results 
being visible at around 6 weeks after the procedure. 
Procedures like dermabrasion
[72]
 and ablative lasers have produced 
similar results. 
However they always carry risk of pigmentation and scarring. 
Prevention is always better than cure. So treatment of acne should 
be begun as early as possible to prevent formation of acne scars in first 
place. 
Platelet rich plasma is a new generation approach to treatment of 
acne scars which utilises body’s own platelets to heal the scars. It causes 
regeneration, rejuvenation and stimulates wound healing.PRP has been 
used in other medical fields for long, but relatively new in field of 
dermatology. It utilises body’s own ability to heal itself. PRP is superior 
to other methods for acne treatment as it is safer, no chances of further 
scarring or damage and comparatively cost effective. It is relatively 
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painless when procedure is done after applying a numbing cream. Studies 
have shown the effectiveness of PRP when used in conjunction with other 
modalities. But there is scarcity of studies showing sole role of platelet 
rich plasma in acne scars. 
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In our study, male patients outnumbered the female patients 
attending the out patient department for the acne scars. This is in contrast 
to belief that females are more concerned about their physical 
appearance. The ratio for male : female was 3: 1. 
The age group most commonly observed was 20-30 years. This is 
the time when the patient although gets rid of the acne lesions, but 
becomes distressed by its sequelae i.e. scars. Most of the patient’s were 
students or working in sales and marketing fields. 
Among the types of scars, it was rolling type of scars (45%) that 
out numbered others followed by combination of both rolling and boxcar 
scars.PRP holds good promise for the management of acne scars. Marked 
to Moderate improvement was seen in 77.5% cases, which is comparable 
with other modalities used for management of acne scars. In most cases 
the improvement became visible at the end of 3rd sitting. 
Improvement in DLQI was also impressive with increase in mean 
DLQI from 22.9 to 8.9 and the patient’s satisfaction ranged from ‘very 
good to good’ in around 80% cases.  
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It  does not hamper daily activity of the patient as it is performed as 
out patient procedure. Entire  procedure takes around 40-45 minutes. 
Minimal side effects like erythema and edema which subsides in 2-6 
hours. 
The procedure can be combined with other methods to get near 
total improvement in acne scars. Also the procedure is cost effective and 
doesn’t require any surgical expertise. To conclude platelet rich plasma 
therapy is easy to perform and provides satisfactory results and that too 
with minimum side effects. 
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ANNEXURE-1 
GOVERNMENT STANLEY MEDICAL COLLEGE HOSPITAL 
DEPARTMENT OF DERMATOLOGY 
PROFORMA 
 
NAME                                          AGE                                          SEX 
OCCUPATION  
ADDRESS 
 
INCOME 
CHIEF COMPLAIN 
H/O PRESENT ILLNESS: 
ONSET 
DURATION 
 
H/O AGGRAVATING FACTORS 
H/O ANY TREATMENT TAKEN , ANY MEDICATION. 
H/O ANY OTHER SYSTEMIC COMPLAIN.  
PAST HISTORY: 
ANY MEDICAL OR SURGICAL ILLNESS 
FAMILY HISTORY: 
PERSONAL HISTORY: 
Smoking 
Diet  
Menstrual history 
General physical examination 
Systemic examination 
Local examination : 
Depth of scars 
Type of acne scars  
Grade of acne (Goodman and Baron Classification of acne scars) 
Active acne present  
 DIAGNOSIS 
INVESTIGATIONS:  
CBC:  HB: 
 TC: 
 DC: 
 ESR: 
 PLATELET: 
LFT: S. BIL: 
 SGOT: 
 SGPT: 
 ALP: 
 STP: 
 S. ALB: 
RFT: S. UREA: 
 S. CREATININE: 
 
SCREENING for HIV and syphilis 
 
 
 
  
CONSENT FORM 
Mr/Miss/Mrs: 
Age/Sex: 
Address: 
 
Phone: 
I undersigned Mr/Miss/Mrs.___________________________ have 
been explained regarding above said procedure in my regional language. 
I am fully aware of the possible side effects and risk involved in this 
procedure. I am also aware that this procedure may not always be 
successful and no guarantee can be made for successful outcome of the 
procedure. 
I have been informed that this study will be done by Dr. Shubhra Shukla. 
I have also been explained that during this procedure if any complication 
arises, it may be given any emergency treatment best suitable without 
asking my prior permission. 
I further state that I have carefully read and understood all the 
information provided in this form and with full conscious mind, I hereby 
give my consent to be involved in this study. 
I also give consent to take my clinical photograph required for the study 
purpose. 
 
Signature/Right Thumb Impression of patient: 
 
Signature/Thumb impression of the parent/guardian (In minors): 
Witness: 
Name:      Signature: 
Date:

MASTER CHART 
S. 
NO 
NAME AGE SEX OCCUPATION 
TYPE OF 
SCAR 
DLQI 
RESPONSE TO 
TREATMENT 
SATISFACTION 
SCORE OF 
PATIENT 
COMPLICATIONS 
Before After 
TRANSIENT 
ERYTHEMA 
 
PAIN 
SEC. 
INFEC-
TION 
1. Arul 21 M Student Rolling 23 7 MARKED Very good + - - 
2. David 28 M Sales job Rolling 21 10 MARKED Good + - - 
3. Shama 25 F Student Rolling 22 9 MARKED Very Good + - - 
4. Satya 28 M Marketing Boxcar 25 9 MODERATE Good + - - 
5. Anitha 29 F Housewife R + B 22 9 MODERATE Good + - - 
6. Shiva 24 M Student Rolling 21 10 MILD Fair + + - 
7. Aiysha 26 F Marketing R + B 21 8 MARKED Very good + - - 
8. Priya 21 F Student Boxcar 24 7 NONE Poor + - - 
9. Akash 25 M Student Rolling 25 10 MODERATE Good + - - 
10. Suresh 33 M Business R + B 23 9 MARKED Good + - - 
11. Vinay 22 M Student R + B 23 9 MARKED Very Good + - - 
12. Ramya 20 F Student Boxcar 25 8 MILD Fair + - - 
13. Karthik 19 M Student R + B 23 10 MARKED Good + - - 
14. Dinesh 27 M Sales job Rolling 24 10 MARKED Good + + - 
15. Praveen 27 M Marketing R + B 24 10 MARKED Very Good + - - 
16. Stephen 19 M Student R + B 25 9 MILD Fair + - - 
17. Swati 28 F Housewife R +B 21 8 MARKED Good + - - 
18. Aasif 25 M Marketing Rolling 22 8 NONE Poor + - - 
19. Kartikeyen 26 M Engineer Boxcar 24 10 MODERATE Good + - - 
20. Sarvanan 22 M Student Rolling 22 9 NONE Poor + - - 
 
MASTER CHART 
S. 
NO 
NAME AGE SEX OCCUPATION 
TYPE OF 
SCAR 
DLQI 
RESPONSE TO 
TREATMENT 
SATISFACTION 
SCORE OF 
PATIENT 
COMPLICATIONS 
Before 
After 
 
 
TRANSIENT 
ERYTHEMA 
 
 
 
PAIN 
 
SEC. 
INFEC-
TION 
21. Sekar 21 M Student Rolling 21 10 MODERATE Very good + - - 
22. Yuvraj 28 M Sales job Rolling 22 9 MODERATE Good + - - 
23. Kavitha 25 F Sales job R + B 25 9 MODERATE Very good + + - 
24. Santosh 29 M Business Rolling 22 10 MILD Fair + - - 
25. Murugan 28 M Marketing Boxcar 23 8 MODERATE Good + - - 
26. Prasanth 26 M Engineer R + B 21 6 MARKED Very Good + - - 
27. Govind 23 M Student Rolling 22 10 MODERATE Good + - - 
28. Shwetha 25 F Student R + B 25 9 MODERATE Very good + - - 
29. Senthil 27 M Sales job R +  B 23 9 MARKED Good + + - 
30. Kumar 21 M Student Rolling 24 8 MODERATE Very good + - - 
31. Vijay 21 M Student Rolling 22 10 MILD Good + - - 
32. Rajsekar 23 M Sales job Rolling 21 10 MARKED Very good + - - 
33. Selvam 26 M Marketing Boxcar 24 8 MILD Fair + - - 
34. Arunraj 25 M Student R + B 21 8 MODERATE Good + - - 
35. Vinayak 29 M Business Boxcar 23 9 MARKED Good + - - 
36. Bhaskar 24 M Sales Boxcar 25 10 MODERATE Good + + - 
37. Keerthi 26 F Engineer Rolling 22 7 MARKED Good + - - 
38. Sohail 32 M Sales Rolling 21 8 MARKED Good + - - 
39. Balaji 20 M Student R + B 21 10 MODERATE Good + - - 
40. Ilakiya 25 F Student Rolling 23 10 MARKED Good + - - 
 
